Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | -1.33% | 57.23 | 6.5% | $169.22m | |
| CTLT | Catalent, Inc. | -1.45% | 78.00 | 2.4% | $132.70m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 0.29% | 17.20 | 14.1% | $101.21m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.08% | 106.60 | 2.4% | $81.66m | |
| UTHR | United Therapeutics Corp. | 0.45% | 117.44 | 14.3% | $68.96m | |
| BHC | Bausch Health Cos., Inc. | 0.29% | 17.20 | 0.0% | $68.81m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 2.80% | 45.09 | 16.8% | $63.68m | |
| PCRX | Pacira Biosciences, Inc. | 0.49% | 57.80 | 10.3% | $55.61m | |
| AXSM | Axsome Therapeutics, Inc. | 1.37% | 83.04 | 1.9% | $51.78m | |
| ZGNX | Zogenix, Inc. | -2.05% | 27.24 | 7.5% | $47.44m | |
| PRGO | Perrigo Co. Plc | 1.68% | 55.17 | 6.8% | $45.82m | |
| MYOK | MyoKardia, Inc. | -0.29% | 92.86 | 1.8% | $45.18m | |
| ARGX | argenx SE | -1.04% | 250.51 | 0.0% | $42.94m | |
| GWPH | GW Pharmaceuticals Plc | -0.16% | 127.90 | 6.2% | $38.07m | |
| ICLR | ICON plc | -2.48% | 169.96 | 4.3% | $37.43m |
Company Profile
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.